AAA enters UK and Irish nuclear medicine markets with the acquisition of Imaging Equipment Ltd
Martedì 04 Marzo 2014 14:22
PDF Stampa E-mail
Advanced Accelerator Applications (“AAA”) announced that it has entered into an agreement to acquire 100% of the shares of Imaging Equipment Ltd (“IEL”), a privately-held UK distributor of nuclear medicine products and technologies, in newly issued AAA shares.
AAA receives orphan drug designation from FDA and EMA for Gallium-68 DOTATATE for use in patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Download the press release (4 March 2014) >>

Read more